Yes, if you will allow it.
I believe we have extraordinary research teams here in Canada, and that they have an impact across the world. However, in most cases, research teams can only demonstrate the value of new technologies that were introduced retroactively. That is much too late. The assessment is being done after the technology has already been introduced into the health care system.
But a technology's performance should be assessed beforehand, using very small samples of patients. In cases where performance has been demonstrated, a more widespread use of that technology can then be recommended. Unfortunately, the current manner of proceeding goes in the opposite direction.